Genomic Tumor Profiling and Precision Oncology
Understanding the mutational profile of a tumor can help to guide therapeutic options. Genomics has enabled the simultaneous analysis of multiple mutations across multiple genes, providing a comprehensive genomic profile of a given tumor. Listen to Dr. Rachel Sanborn of the Providence Cancer Instit…
The Multidisciplinary Approach in the Management of Patients With Lung Cancer, Ep. 11
In this episode, Albert Rizzo, MD, interviews Rachel Sanborn, MD, about the multidisciplinary approach to treating patients with lung cancer, including the team of health care providers that treat lung cancer, how a medical oncologist communicates with the patient, the advancement and impact of bio…
Virtual Tumor Board: Treating EGFR NSCLC After TKI Resistance
In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case involving drug resistance in EGFR mutant NSCLC. This discussion takes the listener through the treatment of EGFR mutant NSCLC after acquired resistance to osimertinib.
Guest: Dr. Yasushi Goto fr…
Advances in Immunotherapy for Lung Cancer: Leaps and Limits
Rachel Sanborn, MD, Medical Director of Clinical Research, Robert W. Franz Cancer Center and Earle A. Chiles Research Institute - A Division of Providence Cancer Institute, Portland Oregon
CME Credit Available for all Providence Providers
In order to claim CME credit, please click on the following…
موتور جستجوی پادکست
می توانید از وب سایت ما برای جستجوی پادکست های3,835,481و قسمت های197,431,008بر اساس افراد، مکان ها یا موضوعات استفاده کنید.
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
